Eduardo Ramos

692 total citations
7 papers, 373 citations indexed

About

Eduardo Ramos is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Eduardo Ramos has authored 7 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Rheumatology. Recurrent topics in Eduardo Ramos's work include Inflammasome and immune disorders (3 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Eduardo Ramos is often cited by papers focused on Inflammasome and immune disorders (3 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Eduardo Ramos collaborates with scholars based in Spain, Switzerland and Germany. Eduardo Ramos's co-authors include Susana Plaza, Juan I. Aróstegui, Josefa Rius, Jordi Yagüe, Consuelo Modesto, Antonio Naranjo, Julia García-Consuegra, Cristina Arnal, Rosa Merino and Thomas Jung and has published in prestigious journals such as Clinica Chimica Acta, Journal of Endocrinology and Arthritis Research & Therapy.

In The Last Decade

Eduardo Ramos

7 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eduardo Ramos Spain	6	235	141	93	90	69	7	373
Yikai Yu China	10	93 0.4×	57 0.4×	44 0.5×	58 0.6×	62 0.9×	21	370
Martin S. Cramer United States	9	179 0.8×	114 0.8×	16 0.2×	72 0.8×	30 0.4×	13	433
Cornelia Keller Switzerland	4	141 0.6×	124 0.9×	23 0.2×	45 0.5×	27 0.4×	4	406
Pablo Mesa-del-Castillo Spain	6	299 1.3×	179 1.3×	44 0.5×	23 0.3×	17 0.2×	12	400
Wendy Wong United States	10	72 0.3×	140 1.0×	105 1.1×	25 0.3×	25 0.4×	21	368
Alfredo Maria Lurati Italy	5	57 0.2×	80 0.6×	33 0.4×	29 0.3×	44 0.6×	11	291
Ludovico Luca Sicignano Italy	10	113 0.5×	50 0.4×	25 0.3×	139 1.5×	23 0.3×	22	307
Fazila Chouiali Canada	9	197 0.8×	228 1.6×	36 0.4×	110 1.2×	85 1.2×	11	491
Maria C. Borrias Netherlands	6	78 0.3×	303 2.1×	26 0.3×	74 0.8×	26 0.4×	8	471

Countries citing papers authored by Eduardo Ramos

Since Specialization

Citations

This map shows the geographic impact of Eduardo Ramos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Ramos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Ramos more than expected).

Fields of papers citing papers by Eduardo Ramos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Ramos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Ramos. The network helps show where Eduardo Ramos may publish in the future.

Co-authorship network of co-authors of Eduardo Ramos

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Ramos. A scholar is included among the top collaborators of Eduardo Ramos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Ramos. Eduardo Ramos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Kuemmerle‐Deschner, Jasmin, Eduardo Ramos, Norbert Blank, et al.. (2011). Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Research & Therapy. 13(1). 85 indexed citations

Fonseca, Francisco Antônio Helfenstein, Rui Póvoa, Antonio C.C Carvalho, et al.. (2009). High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation. Clinica Chimica Acta. 406(1-2). 113–118. 21 indexed citations

Izar, Maria Cristina de Oliveira, Cristina M. Monteiro, Rui Póvoa, et al.. (2009). Early Increase in Autoantibodies Against Human Oxidized Low-Density Lipoprotein in Hypertensive Patients After Blood Pressure Control. American Journal of Hypertension. 23(2). 208–214. 19 indexed citations

Kümmerle‐Deschner, Jasmin, Norbert Blank, Joachim Roesler, et al.. (2008). 12.4 ACZ885 (canakinumab), a new IL-1 beta blocking monoclonal antibody provides long-lasting remission in children with cryopyrin associated periodic syndrome (CAPS). Pediatric Rheumatology. 6(S1). 3 indexed citations

Aróstegui, Juan I., Cristina Arnal, Rosa Merino, et al.. (2007). NOD2 gene–associated pediatric granulomatous arthritis: Clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin‐1 blockade in a Spanish cohort. Arthritis & Rheumatism. 56(11). 3805–3813. 165 indexed citations

Aróstegui, Juan I., Anna Aldea, Consuelo Modesto, et al.. (2004). Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis & Rheumatism. 50(12). 4045–4050. 73 indexed citations

Sánchez‐Margalet, Víctor, Eduardo Ramos, José Mateo, et al.. (1997). Normal pancreastatin-like and increased post-glucose insulin levels in young offspring of insulin-resistant non-obese essential hypertensive patients. Journal of Endocrinology. 153(2). 313–318. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact